AI summary

90% confidence

MES research in membrane, bacteria. Abstract Innovative biohydroxylation catalysts for the preparation o...

Generated by MESSAI extraction pipeline · review against source PDF

Extraction

Reported parameters

1 extracted value

View extracted values

No 3D model is mapped to this paper yet. Parameter ranges above still place reported values on the literature distribution.

Abstract

Abstract Innovative biohydroxylation catalysts for the preparation of drug metabolites were developed from scratch. A set of bacterial and fungal sequences of putative and already known bifunctional P450 enzymes was identified by protein sequence alignments, expressed in Escherichia coli and characterised. Notably, a fungal self‐sufficient cytochrome P450 (CYP) from Aspergillus fumigatus turned out to be especially stable during catalyst preparation and application and also in presence of organic co‐solvents. To enhance the catalytic activity and broaden the substrate specificity of those variants with high expression levels prominent single mutations were introduced. Selected improved variants were then used as lyophilised bacterial lysates for the synthesis of 4′‐hydroxydiclofenac and 6‐hydroxychlorzoxazone, the two metabolites of active pharmaceutical compounds diclofenac and chlorzoxazone representing the same metabolites as generated by human P450s.

Keywords

Cytochrome P450BifunctionalEscherichia coliBiochemistryAspergillus fumigatusEnzyme

Identifiers

Journal
Advanced Synthesis & Catalysis
Year
2009